Rochester, NY (PRWEB) April 21, 2014
polyDNA is happy to announce the launch of Novirin. This new natural antiviral remedy has the same five natural ingredients as the highly successful Gene-Eden-VIR. The difference between the two is that Novirin has higher quality, more expensive ingredients.
Why did polyDNA decide to sell two products that share the same formula? The reason is that Gene-Eden-VIR perfectly fits the needs of customers who seek an effective, yet affordable product. In contrast, Novirin is suitable for those who wish to purchase the most effective natural antiviral product on the market.
Novirin hits the online market and becomes available on April 21, 2014. Both Novirin and Gene-Eden-VIR help the immune system target latent viruses, and reduce symptoms of latent viral infections with the Herpes (HSV), Human Papillomavirus (HPV), Hepatitis B and C (HBV and HCV), the Epstein Barr Virus (EBV), and the Human Cytomegalovirus (CMV) viruses. Individuals who suffer from an infection with one or more of these viruses can order Novirin at, http://www.novirin.com and Gene-Eden-VIR at, http://www.gene-eden-vir.com.
Interest in natural antiviral formulas, such as the one found in Novirin and Gene-Eden-VIR, has grown over the past two years.
“We’re very proud of the success Gene-Eden-VIR has enjoyed with customers worldwide. We are especially proud of the clinical study that showed that the Novirin/Gene-Eden-VIR formula decreases the symptoms of viral infections.” - Mike Evans, polyDNA
Previous customers will recognize the same effective formula in Novirin that was tested in two post-marketing clinical studies published in September 2013 and March 2014, respectively, in the peer reviewed medical journal Pharmacy & Pharmacology. However, Novirin contains higher quality, more expensive ingredients. These ingredients were selected to fight latent viruses even more effectively than Gene-Eden-VIR.
Interested individuals can view the two published studies here, http://cbcd.net/Gene-Eden-VIR-Clinical-Study.php and http://cbcd.net/Gene-Eden-VIR-Decreases-Fatigue-Clinical-Study.php.
In a post marketing clinical study published on August 12, 2013 in the medical journal Pharmacology & Pharmacy in a special edition on Advances in Antiviral Drugs, researchers showed that the product that delivered the Novirin/Gene-Eden-VIR formula is safe and effective (1).
Additionally, up to 70% of those studied reported a decrease in symptoms associated with a latent viral infection, and users of the Novirin/Gene-Eden-VIR formula experienced an increase in overall health (1).
Each ingredient of Novirin was chosen through a scientific approach. Scientists scanned thousands of scientific and medical papers published in various medical and scientific journals around the world to identify the highest quality, safest, most effective natural ingredients that target latent viruses.
A second clinical study showed that the Novirin/Gene-Eden-VIR formula decreased physical and mental fatigue. (See Pharmacology & Pharmacy, from March, 2014) (2).
Most scientists and physicians believe that latent viruses cause no diseases or symptoms. The FDA even states on its website: “Some viruses, however, can enter a state known as latency in which the virus is not being replicated. In the latent state, the virus does not cause disease.” (See the FDA, from October 24, 2001) (3). As a result, current standard medical practices don’t target latent viruses.
In contrast to this belief, the Microcompetition with Foreign DNA theory, proposed by Hanan Polansky in 2003, describes how viruses, during their latent phase, can cause a chronic disease. (See The CBCD, “Microcompetition with Foreign DNA and the Origin of Chronic Disease.” Published in 2003) (4). The Novirin/Gene-Eden-VIR formula is based on the Microcompetition Theory.
All orders of Novirin are completely confidential, and no information is shared or sold to any third party. Privacy is assured.
(1) Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Published in September 2013.
(2) -Eden-VIR Decreased Physical and Mental Fatigue in a Post Marketing Clinical Study That Followed FDA Guidelines; Results Support Microcompetition Theory. Published in March 2014.
(3) FDA - Long-Term Follow-Up Of Gene Transfer Patients. Published October 24, 2001.
(4) The Center for the Biology of Chronic Disease - Microcompetition with Foreign DNA and the Origin of Chronic Disease. Published in 2003.
polyDNA is a biotechnology company that develops dietary supplements using the unique scientific method developed by Dr. Hanan Polansky, which is based on Computer Intuition.
In addition to his unique scientific method, Dr. Polansky published the highly acclaimed scientific discovery, called Microcompetition with Foreign DNA. The discovery explains how foreign DNA fragments, and specifically, DNA of latent viruses, cause most major diseases.
polyDNA developed Novirin, an antiviral natural remedy that helps the immune system kill latent viruses.